Patient Involvement in the Design of a Phase III Trial Comparing Intensity-modulated Proton Therapy and Intensity-modulated Radiotherapy for Oropharyngeal Cancer

Affiliations

¹ The Christie NHS Foundation Trust, Manchester, UK.
² Weston Park Hospital, Sheffield, UK.
³ The Institute of Cancer Research, Clinical Trials and Statistics Unit, London, UK.
⁴ Patient Representative, Leeds, UK.
⁵ Manchester University NHS Foundation Trust, The University of Manchester, Public Programmes Team, Manchester, UK.
⁶ The University College London Hospital, London, UK.
⁷ The Royal Marsden NHS Foundation Trust, London, UK.
⁸ St James' University Hospital, Leeds, UK.
⁹ Division of Cancer Science, The University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, Manchester, UK.
¹⁰ The Christie NHS Foundation Trust, Manchester, UK. Electronic address: david.thomson@christie.nhs.uk.

Editorial

C Hague et al. Clin Oncol (R Coll Radiol). 2018 May.

. 2018 May;30(5):274-276.

doi: 10.1016/j.clon.2018.01.018. Epub 2018 Feb 17.

¹ The Christie NHS Foundation Trust, Manchester, UK.
² Weston Park Hospital, Sheffield, UK.
³ The Institute of Cancer Research, Clinical Trials and Statistics Unit, London, UK.
⁴ Patient Representative, Leeds, UK.
⁵ Manchester University NHS Foundation Trust, The University of Manchester, Public Programmes Team, Manchester, UK.
⁶ The University College London Hospital, London, UK.
⁷ The Royal Marsden NHS Foundation Trust, London, UK.
⁸ St James' University Hospital, Leeds, UK.
⁹ Division of Cancer Science, The University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, Manchester, UK.
¹⁰ The Christie NHS Foundation Trust, Manchester, UK. Electronic address: david.thomson@christie.nhs.uk.